Toshiyasu Imai

This inventor holds 17 USPTO granted patents and 10 published patent applications, plus 9 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Research. Top assignees: Nippon Chemiphar Co., Ltd., Kyushu University. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyasu Imai. Retrieved from https://idiyas.com/inventor/toshiyasu-imai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 10)

% Patents Active = 88.2

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Saitama, JP (2016 - 2018)
Tokyo, JP (2018 - 2022)
Misato, JP (2013 - 2024)

Company Filing History:

17 out of 132

Nippon Chemiphar Co., Ltd.

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Cough Treatment

Diabetic Neuropathy

Multiple Sclerosis

P2X4 Receptor Antagonist

Diazepinedione Derivative

Pharmaceutical Innovation

Neuropathic Pain

Drug Formulation

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233071 - Medicament for treating cough (2025-02-25),

2. 12116351 - P2X4 receptor antagonist (2024-10-15),

3. 12090158 - Medicine for diabetic peripheral neuropathy (2024-09-17),

4. 11918589 - Medicament for treatment of multiple sclerosis (2024-03-05),

5. 11666582 - Medicament for treating cough (2023-06-06),

6. 11434207 - P2X4 receptor antagonist (2022-09-06),

7. 10633349 - P2X4 receptor antagonist (2020-04-28),

8. 10472333 - P2X4 receptor antagonist (2019-11-12),

9. 10150744 - P2X4 receptor antagonist (2018-12-11),

10. 9969700 - P2X4 receptor antagonist (2018-05-15),

11. 9873683 - P2X4 receptor antagonist (2018-01-23),

12. 9382236 - P2X4 receptor antagonist (2016-07-05),

13. 8962613 - [object Object] (2015-02-24),

14. 8778933 - Diazepinedione derivative (2014-07-15),

15. 8680110 - [object Object] (2014-03-25),

Title: Toshiyasu Imai: Innovator in Medicinal Chemistry

Introduction

Toshiyasu Imai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutics. With a total of 17 patents to his name, Imai's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Imai's latest patents include a medicament for treating cough, which features a compound that acts as a P2X4 receptor antagonist. This invention aims to provide an effective solution for preventing or treating coughs. Another notable patent involves a diazepine derivative that serves as a P2X4 receptor antagonist, showcasing Imai's innovative approach to drug development.

Career Highlights

Throughout his career, Toshiyasu Imai has worked with notable organizations such as Nippon Chemiphar Co., Ltd. and Kyushu University. His experience in these institutions has allowed him to refine his expertise in medicinal chemistry and contribute to groundbreaking research.

Collaborations

Imai has collaborated with esteemed colleagues, including Shogo Sakuma and Kazuhide Inoue. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.

Conclusion

Toshiyasu Imai's contributions to medicinal chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.